Nanomedicine – How Nanotechnology Can Be Used in the Healthcare/Drug Markets for Humans and Animals
Last Updated on Wednesday, 27 July 2005 10:19 Written by admin Wednesday, 27 July 2005 10:19
The field of nanomedicine offers ever more breathless promises of new diagnoses and cures as well as ways of improving human performance. The US National Science Foundation (NSF) expects nanotechnology to account for around half of all pharmaceutical industry sales by 2010. What is less hyped is that the same impact is likely to hit the animal health market – either as nanotechnologies show their worth in human medicine or as a proving ground for more controversial approaches to nanomedicine, such as using DNA nanocapsules.
This entry was posted on Wednesday, July 27th, 2005 at 10:19 am and is filed under Discoveries, Innovations and Patents, North America, Research Projects.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.
Main Menu
- Home
- About Bioscreening.net
- Glossary
- Biotechnology Glossary A-I
- Biotechnology Glossary J-Q
- Biotechnology Glossary R-Z
- Bird Flu
- Cheminformatic Glossary
- Endotoxins
- Fullerenes
- Genipin
- Gossypol (Gossipol)
- Grants, Venture Capital, and Government Funding
- High-throughput screening
- Lipinski Rule-of-Five
- Mumie
- Natural Medicine
- Rule-of-Three (Ro3)
- Targeted Libraries
- Web Directory